Fong KM - Search Results

1

Expression profiling defines a recurrence signature in lung squamous cell carcinoma.

Larsen JE, Pavey SJ, Passmore LH, Bowman R, Clarke BE, Hayward NK, Fong KM. Larsen JE, et al. Among authors: fong km. Carcinogenesis. 2007 Mar;28(3):760-6. doi: 10.1093/carcin/bgl207. Epub 2006 Nov 1. Carcinogenesis. 2007. PMID: 17082175

2

KRAS codon 12 mutations in Australian non-small cell lung cancer.

Fong KM, Zimmerman PV, Smith PJ. Fong KM, et al. Aust N Z J Med. 1998 Apr;28(2):184-9. doi: 10.1111/j.1445-5994.1998.tb02967.x. Aust N Z J Med. 1998. PMID: 9612526

3

Re: Effects of N-(4-hydroxy-phenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers.

Bowman R, Clarke B, Duhig E, Larsen J, Fong K. Bowman R, et al. J Natl Cancer Inst. 2002 Jun 19;94(12):949-50; author reply 950-1. doi: 10.1093/jnci/94.12.949-a. J Natl Cancer Inst. 2002. PMID: 12072549 No abstract available.

4

'Iron lung': distinctive bronchoscopic features of acute iron tablet aspiration.

Kim ST, Kaisar OM, Clarke BE, Vandenburg RA, Allen DH, Bell SC, Fong KM. Kim ST, et al. Among authors: fong km. Respirology. 2003 Dec;8(4):541-3. doi: 10.1046/j.1440-1843.2003.00506.x. Respirology. 2003. PMID: 14708558

5

A molecular chink in the lung cancer armour.

Fong KM, Bowman R. Fong KM, et al. Respirology. 2004 Nov;9(4):426-7. doi: 10.1111/j.1440-1843.2004.00672c.x. Respirology. 2004. PMID: 15612952 Review. No abstract available.

6

Cochrane systematic reviews of treatments for lung cancer.

Fong KM, Yang IA, Zimmerman PV, Bowman RV. Fong KM, et al. Respir Med. 2005 Sep;99(9):1071-8. doi: 10.1016/j.rmed.2005.05.002. Respir Med. 2005. PMID: 15955688 Free article. Review.

7

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.

Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. Larsen JE, et al. Among authors: fong km. Cancer Causes Control. 2005 Jun;16(5):579-85. doi: 10.1007/s10552-004-7842-3. Cancer Causes Control. 2005. PMID: 15986113

8

CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.

Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. Larsen JE, et al. Among authors: fong km. Carcinogenesis. 2006 Mar;27(3):525-32. doi: 10.1093/carcin/bgi227. Epub 2005 Sep 29. Carcinogenesis. 2006. PMID: 16195240

9

Why we need a population-based approach to clinical indicators for cancer: a case study using microscopic confirmation of lung cancer in Queensland.

Coory M, Fong K, Bowman R, Hall L. Coory M, et al. Intern Med J. 2006 Jun;36(6):389-92. doi: 10.1111/j.1445-5994.2006.01074.x. Intern Med J. 2006. PMID: 16732867

10

Epigenetics of lung cancer.

Bowman RV, Yang IA, Semmler AB, Fong KM. Bowman RV, et al. Among authors: fong km. Respirology. 2006 Jul;11(4):355-65. doi: 10.1111/j.1440-1843.2006.00859.x. Respirology. 2006. PMID: 16771905 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters